Elastrin Therapeutics
Manufacturing · South Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Laurel Branch Ln, Simpsonville, South ...Phone Number
(864) 650-7155Website
www.elastrin.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Elastrin Therapeutics
Elastrin Therapeutics is a South Carolina-based biotech developing novel therapies to reverse cardiovascular disease. Its underlying technology was developed by Dr. Naren Vyavahare over the last 20 years at Clemson University. The company's team has built a proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting.Explore more
Elastrin Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elastrin Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Elastrin Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Elastrin Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Elastrin Therapeutics
Elastrin Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Elastrin Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Elastrin Therapeutics launches new products
Funding: Get notified immidiatlly once Elastrin Therapeutics has new funding data
Check out if Elastrin Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Elastrin Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Elastrin Therapeutics
Compare insights from companies similar to Elastrin Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Elastrin Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Elastrin Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Elastrin Therapeutics.
Elastrin Therapeutics financials insights
Gather financial insights about Elastrin Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$2.5M
2022
Unspecified
$10M
Elastrin Therapeutics Tech Stack
A closer look at the technologies used by Elastrin Therapeutics
See more technologies
Elastrin Therapeutics News & Media
Elastrin Therapeutics Announces Newly Formed Scientific Advisory Board
GREENVILLE, S.C.--(BUSINESS WIRE)--Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation of its Scientific Advisory Board. The Board is comprised of leading industry and university experts in cardiovascular research and clinical development. Former CMO of Elastrin Therapeutics, Dr. Pedro M. Quintana Diez, will act as chairman. Elastrin Therapeutics’
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Elastrin Therapeutics
Sign Up For FreeTo access detailed company insights
Elastrin Therapeutics is a South Carolina-based biotech developing novel therapies to reverse cardiovascular disease. Its underlying technology was developed by Dr. Naren Vyavahare over the last 20 years at Clemson University. The company's team has built a proprietary platform that targets and restores degraded elastin by removing the harmful calc... Read More
